CVG:FRA
CSPC Pharmaceutical Group Ltd
€0.89
arrow_downward
-0.22%(-0.0020) 1 دن
30 اپریل, 10:00:00 PM GMT +2 · EUR
search
تمام علامات
1 دن
5 دن
1 ماہ
6 ماہ
YTD
1 سال
5 سال
زیادہ سے زیادہ
| علامت | قیمت | تبدیلی | % تبدیلی |
|---|
insights_autoCVG کے لیے سرفہرست بصیرتیں تخلیق کی جا رہی ہیں...
کھولیں
€0.89
اعلی
€0.89
کم
€0.89
مارکیٹ کی سرمایہ کاری
۹۶٫۹۰ ارب
اوسط والیوم
۱۰۱٫۰۰
والیوم
۰٫۰۰
52 ہفتے میں اعلی
€1.25
52 ہفتے کا کم
€0.63
ملازمین کی تعداد
۲۰ ہزار
خبریں اور کہانیاں
ویب پر موجود ذرائع سے
Simply Wall Street
·
11 منٹ پہلے
Cimpress (CMPR) Is Up 14.4% After Raising FY26 Guidance Again And Highlighting Profitability Targets
GuruFocus
·
28 منٹ پہلے
Bank of America Reports Cautious Sentiment Amid S&P 500 Rally
پروفائل
CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province.
CSPC produces both active pharmaceutical ingredient and formulations. API products include
penicillin, cefalosporins, synthetic vitamins, caffeine and ranitidine. Formulations include antibiotics, butylphthalide and analgesics, in addition to nearly 1,000 other products.
CSPC's 15,000 employees are divided among more than ten subsidiaries, including CSPC Zhongrun, Weisheng, Zhongnuo and NBP.
CSPC Pharma's total assets are valued above RMB 8 billion. In 2007, CSPC Pharma achieved sales of RMB 8 billion and net income of RMB 485 million. Direct exports of US$300 million ranked CSPC first among China's pharmaceutical enterprises.
One subsidiary, China Pharmaceutical Group Co., Ltd is based in Hong Kong. It is listed on the Hang Seng China-Affiliated Corporations Index. In 2003 and 2004, China Pharma was listed as one of 100 excellent listed companies with turnover less than $1 billion.
CSPC Pharma is recognized as one of China's “500 Most Valuable Chinese Brands” and “Top 500 Chinese Enterprises.” Wikipedia
CSPC Pharmaceutical Group Ltd کے بارے میں
AI مواد میں غلطیاں شامل ہو سکتی ہیں۔ مزید جانیں